40
Participants
Start Date
June 12, 2024
Primary Completion Date
December 1, 2025
Study Completion Date
January 1, 2026
Autologous blood cell salvage with in-house device
In addition to standard procedures in this patient population, study participants will receive point-of-care analysis of platelet function and coagulation (laboratory analysis and viscoelastic tests, if not already provided by the responsible anesthesiologist) based on the clinical situation, at different time points before and after retransfusion of processed cell salvage blood.
Autologous cell salvage with i-Sep SAME device
In addition to standard procedures in this patient population, study participants will receive point-of-care analysis of platelet function and coagulation (laboratory analysis and viscoelastic tests, if not already provided by the responsible anesthesiologist) based on the clinical situation, at different time points before and after retransfusion of processed cell salvage blood.
RECRUITING
Department of Anesthesiology and Pain Medicine, Bern
University Hospital, Geneva
OTHER
University of Zurich
OTHER
Insel Gruppe AG, University Hospital Bern
OTHER